Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference

GlobeNewswire August 1, 2017

iCAD to Report Second Quarter 2017 Financial Results on Tuesday, August 8

GlobeNewswire July 31, 2017

Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition

GlobeNewswire July 27, 2017

iCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer

GlobeNewswire July 19, 2017

Carolina Breast Imaging Specialists Adopts iCAD’s Advanced Artificial Intelligence Technology for Digital Breast 3D Tomosynthesis

GlobeNewswire June 6, 2017

iCAD to Participate in Two Upcoming Investor Conferences

GlobeNewswire May 22, 2017

First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting

GlobeNewswire May 5, 2017

iCAD Reports First-Quarter 2017 Financial Results

GlobeNewswire May 2, 2017

Investor Network: iCAD, Inc. to Host Earnings Call

Accesswire May 2, 2017

iCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre and Monash Health in Australia

GlobeNewswire May 1, 2017

iCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting

PR Newswire April 26, 2017

iCAD to Report First Quarter 2017 Financial Results on Tuesday, May 2

GlobeNewswire April 24, 2017

Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting

PR Newswire April 20, 2017

iCAD To Showcase PowerLook Tomo Detection Technology At SBI/ACR Breast Imaging Symposium

PR Newswire April 6, 2017

iCAD Receives FDA Approval For PowerLook Tomo Detection

PR Newswire March 27, 2017

iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System

PR Newswire March 9, 2017

iCAD Reports Fourth Quarter and Full Year 2016 Financial Results

GlobeNewswire March 8, 2017

iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017

PR Newswire March 3, 2017

iCAD to Present at the 29th Annual ROTH Conference

GlobeNewswire March 2, 2017

iCAD to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call on Wednesday, March 8, 2017

GlobeNewswire February 27, 2017